Transforming growth factor-β1 and TGF-β2 act synergistically in the fibrotic pathway in oral submucous fibrosis: An immunohistochemical observation

Background and objectives: Oral Submucous Fibrosis (OSF) is a potentially malignant oral disorder which leads to fibrosis of the oral mucosa and has a high rate of malignant transformation. The consumption of various forms of areca nut is causatively linked to the condition. The constituents of arec...

Full description

Saved in:
Bibliographic Details
Main Authors: Venkatesh Viswanath Kamath, Shruti Krishnamurthy, Krishnanand P Satelur, Komali Rajkumar
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2015-01-01
Series:Indian Journal of Medical and Paediatric Oncology
Subjects:
Online Access:http://www.ijmpo.org/article.asp?issn=0971-5851;year=2015;volume=36;issue=2;spage=111;epage=116;aulast=Kamath
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850165836153618432
author Venkatesh Viswanath Kamath
Shruti Krishnamurthy
Krishnanand P Satelur
Komali Rajkumar
author_facet Venkatesh Viswanath Kamath
Shruti Krishnamurthy
Krishnanand P Satelur
Komali Rajkumar
author_sort Venkatesh Viswanath Kamath
collection DOAJ
description Background and objectives: Oral Submucous Fibrosis (OSF) is a potentially malignant oral disorder which leads to fibrosis of the oral mucosa and has a high rate of malignant transformation. The consumption of various forms of areca nut is causatively linked to the condition. The constituents of areca nut activate several pro-fibrotic cytokines, chiefly transforming growth factor-β1, β2, which leads to an increased deposition and decreased degradation of extracellular matrix and collagen. TGF-β1, β2 probably represent the major pathway in the deposition of collagen fibres in this condition. The present study aims to identify and correlate the expressions of TGF-β1 and TGF-β2 immunohistochemically on paraffin sections of various stages of OSF. A comparison was also made between normal oral mucosa and scar tissue and OSF to judge the mode, extent and type of expression of TGF β1, β2. Methods: The expression of TGF-β1 antibody (8A11, NovusBio, USA) and TGF-β2 antibody (TB21, NovusBio, USA) was detected immunohistochemically on paraffin sections of 58 and 70 cases of OSF respectively, 10 cases of normal oral mucosal tissue and 4 cases of scar tissue. A mapping of the positivity of the two cytokines was done using JenOptik camera and ProReg image analysis software. The results were statistically analysed using one way ANOVA and students "t" test. Results: Expression of TGF-β1 and TGF-β2 was more in OSF as compared with normal oral mucosa, scar/keloid tissue showing highest values. Positivity for both the markers was seen in epithelium, around the blood vessels, in areas of inflammatory infiltrate, fibroblasts and in muscles. TGF-β1 expression was higher and more intense than that of TGF-β2 in all the cases. TGF-β2 was restricted in its expression to submucosal area with minimal involvement of the epithelium and the deeper muscle tissue. Conclusion: TGF-β1 is the most prominent cytokine in the fibrotic pathway and TGF-β2 plays a contributory role.
format Article
id doaj-art-e1e2e3397001405ab84776baf13f70c8
institution OA Journals
issn 0971-5851
language English
publishDate 2015-01-01
publisher Thieme Medical and Scientific Publishers Pvt. Ltd.
record_format Article
series Indian Journal of Medical and Paediatric Oncology
spelling doaj-art-e1e2e3397001405ab84776baf13f70c82025-08-20T02:21:38ZengThieme Medical and Scientific Publishers Pvt. Ltd.Indian Journal of Medical and Paediatric Oncology0971-58512015-01-0136211111610.4103/0971-5851.158842Transforming growth factor-β1 and TGF-β2 act synergistically in the fibrotic pathway in oral submucous fibrosis: An immunohistochemical observationVenkatesh Viswanath KamathShruti KrishnamurthyKrishnanand P SatelurKomali RajkumarBackground and objectives: Oral Submucous Fibrosis (OSF) is a potentially malignant oral disorder which leads to fibrosis of the oral mucosa and has a high rate of malignant transformation. The consumption of various forms of areca nut is causatively linked to the condition. The constituents of areca nut activate several pro-fibrotic cytokines, chiefly transforming growth factor-β1, β2, which leads to an increased deposition and decreased degradation of extracellular matrix and collagen. TGF-β1, β2 probably represent the major pathway in the deposition of collagen fibres in this condition. The present study aims to identify and correlate the expressions of TGF-β1 and TGF-β2 immunohistochemically on paraffin sections of various stages of OSF. A comparison was also made between normal oral mucosa and scar tissue and OSF to judge the mode, extent and type of expression of TGF β1, β2. Methods: The expression of TGF-β1 antibody (8A11, NovusBio, USA) and TGF-β2 antibody (TB21, NovusBio, USA) was detected immunohistochemically on paraffin sections of 58 and 70 cases of OSF respectively, 10 cases of normal oral mucosal tissue and 4 cases of scar tissue. A mapping of the positivity of the two cytokines was done using JenOptik camera and ProReg image analysis software. The results were statistically analysed using one way ANOVA and students "t" test. Results: Expression of TGF-β1 and TGF-β2 was more in OSF as compared with normal oral mucosa, scar/keloid tissue showing highest values. Positivity for both the markers was seen in epithelium, around the blood vessels, in areas of inflammatory infiltrate, fibroblasts and in muscles. TGF-β1 expression was higher and more intense than that of TGF-β2 in all the cases. TGF-β2 was restricted in its expression to submucosal area with minimal involvement of the epithelium and the deeper muscle tissue. Conclusion: TGF-β1 is the most prominent cytokine in the fibrotic pathway and TGF-β2 plays a contributory role.http://www.ijmpo.org/article.asp?issn=0971-5851;year=2015;volume=36;issue=2;spage=111;epage=116;aulast=KamathImmunohistochemistryoral submucous fibrosisscartransforming growth factor-beta1transforming growth factor-beta2
spellingShingle Venkatesh Viswanath Kamath
Shruti Krishnamurthy
Krishnanand P Satelur
Komali Rajkumar
Transforming growth factor-β1 and TGF-β2 act synergistically in the fibrotic pathway in oral submucous fibrosis: An immunohistochemical observation
Indian Journal of Medical and Paediatric Oncology
Immunohistochemistry
oral submucous fibrosis
scar
transforming growth factor-beta1
transforming growth factor-beta2
title Transforming growth factor-β1 and TGF-β2 act synergistically in the fibrotic pathway in oral submucous fibrosis: An immunohistochemical observation
title_full Transforming growth factor-β1 and TGF-β2 act synergistically in the fibrotic pathway in oral submucous fibrosis: An immunohistochemical observation
title_fullStr Transforming growth factor-β1 and TGF-β2 act synergistically in the fibrotic pathway in oral submucous fibrosis: An immunohistochemical observation
title_full_unstemmed Transforming growth factor-β1 and TGF-β2 act synergistically in the fibrotic pathway in oral submucous fibrosis: An immunohistochemical observation
title_short Transforming growth factor-β1 and TGF-β2 act synergistically in the fibrotic pathway in oral submucous fibrosis: An immunohistochemical observation
title_sort transforming growth factor β1 and tgf β2 act synergistically in the fibrotic pathway in oral submucous fibrosis an immunohistochemical observation
topic Immunohistochemistry
oral submucous fibrosis
scar
transforming growth factor-beta1
transforming growth factor-beta2
url http://www.ijmpo.org/article.asp?issn=0971-5851;year=2015;volume=36;issue=2;spage=111;epage=116;aulast=Kamath
work_keys_str_mv AT venkateshviswanathkamath transforminggrowthfactorb1andtgfb2actsynergisticallyinthefibroticpathwayinoralsubmucousfibrosisanimmunohistochemicalobservation
AT shrutikrishnamurthy transforminggrowthfactorb1andtgfb2actsynergisticallyinthefibroticpathwayinoralsubmucousfibrosisanimmunohistochemicalobservation
AT krishnanandpsatelur transforminggrowthfactorb1andtgfb2actsynergisticallyinthefibroticpathwayinoralsubmucousfibrosisanimmunohistochemicalobservation
AT komalirajkumar transforminggrowthfactorb1andtgfb2actsynergisticallyinthefibroticpathwayinoralsubmucousfibrosisanimmunohistochemicalobservation